PharmaTelevision - The EBD Group's Conference Plans for 2009

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: The EBD Group's Conference Plans for 2009

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

At BioEurope 2008 in Mannheim, Carola Schropp, CEO of the EBD Group, took the time to talk to Fintan Walton about recent changes in the industry and the important role that partnering still plays. As the biopharma community looks to the future and starts to assess the damage caused by recent economic events, Ms. Schropp feels confident that partnering conferences will continue to be essential in enabling deal making. She outlines the meetings that are planned for next year, including the new EuroMedtech conference, which will take place in June 2009.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Bio Europe conferences:Focused on partnering and networking

Fintan Walton:

Hello and welcome to PharmaVentures business review. In this special interview at Bio Europe here in Mannheim, Germany with the President of the EBD Group Carola Schropp Welcome to the show.

Carola Schropp:

Thanks for having me.

Fintan Walton:

Carola You are as I said you are the president of the EBD Group, you founded this organization and it's is made a considerable name in running conferences every year back over the last 10-years focused on partnering, so how does that all come about and what's changed in the time since it all started?

Carola Schropp:

It started in 94, 95 with you know at the time you had a substantial number of biotech companies in the United States and they had a need to collaborate with the European Pharmaceutical industry. So it started with the trade mission that we then made into a conference by Europe for the first time to place under our organization in 2000-1996.

Fintan Walton:

Right, so the key thing here was clearly was to try and get US companies talking to European companies and that the whole thing what was unique I think was this partnering component?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Carola Schropp

Chief Executive Officer

Ms Schroppfounded the EBD Group in January of 1993. In the past 10 years, Ms.Schropp has built EBD into one of the leading business development organizations using conferences as a venue to facilitate partnerships. For more than 20 years,Carola Schropp has been a strategic planning and business development consultant to technology firms. In 1995, she started the BIO-Europe Conference together with BIO to provide a forum for the Biotechnology and the Pharma industry to get together. Before EBD, Carola worked for other consulting companies including as Managing Director of ExperConsult, Inc., and Marketing Director at European Marketing and Sales,(EMS) LTD a consulting company headquartered in London. From 1985 to 1989 she held consultant and senior consultant positions at International Data Corporation in Framingham, MA. Ms Schropp has written a number of articles published in industry publications, such as Nature Biotechnology,BioEntrepreneur, Genetic Engineering News, BioPharm, GIT and BioCommerce Data Ltd.

EBD Group

EBD Group.The leading firm for partnering in the life sciences,EBD Group organizes landmark conferences for the biotechnology and pharmaceutical industries. Building on this expertise, and with an unrivaled access to major players in these markets,EBD provides partnering services to other event organizers, and hands-on business development consultancy to support strategic partnering worldwide. EBD operates from offices in North America and Europe. Since the firms inception in 1993, EBD people have been partnering experts, driving together biotech innovation with the muscle of big pharma, where partnerships, as much as products, are generating spectacular growth.